COVID-19 Response

AEI clients in the COVID-19 fight: Takeda

Takeda Developing Plasma Therapy for COVID-19 Patients.

Takeda is developing a plasma-derived hyperimmune globulin therapy for COVID-19. TAK-888 could be used to treat severely ill patients and could potentially help at-risk health care workers develop immunity.

Click to read full article

Post Date

04/15/20